SARS-CoV-2, the autoimmune virus
- PMID: 33130000
- PMCID: PMC7598743
- DOI: 10.1016/j.autrev.2020.102695
SARS-CoV-2, the autoimmune virus
Figures
Similar articles
-
Rogue antibodies could be driving severe COVID-19.Nature. 2021 Feb;590(7844):29-31. doi: 10.1038/d41586-021-00149-1. Nature. 2021. PMID: 33469204 No abstract available.
-
SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage.Front Immunol. 2021 Aug 10;12:705772. doi: 10.3389/fimmu.2021.705772. eCollection 2021. Front Immunol. 2021. PMID: 34447375 Free PMC article.
-
The impact of COVID-19 on autoimmune diseases.Prog Mol Biol Transl Sci. 2025;213:315-345. doi: 10.1016/bs.pmbts.2025.01.007. Epub 2025 Feb 25. Prog Mol Biol Transl Sci. 2025. PMID: 40246348 Review.
-
Covid-19 and oral diseases: Crosstalk, synergy or association?Rev Med Virol. 2021 Nov;31(6):e2226. doi: 10.1002/rmv.2226. Epub 2021 Mar 1. Rev Med Virol. 2021. PMID: 33646645 Free PMC article. Review.
-
[The role of HLA genes: from autoimmune diseases to COVID-19].Probl Endokrinol (Mosk). 2020 Sep 1;66(4):9-15. doi: 10.14341/probl12470. Probl Endokrinol (Mosk). 2020. PMID: 33351354 Review. Russian.
Cited by
-
Autoantigens of Small Nerve Fibers and Human Coronavirus Antigens: Is There a Possibility for Molecular Mimicry?Curr Microbiol. 2024 Sep 19;81(11):366. doi: 10.1007/s00284-024-03885-5. Curr Microbiol. 2024. PMID: 39297982
-
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study.Biomedicines. 2024 Jun 13;12(6):1306. doi: 10.3390/biomedicines12061306. Biomedicines. 2024. PMID: 38927513 Free PMC article.
-
Aptamer BC 007's Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies.Viruses. 2021 May 18;13(5):932. doi: 10.3390/v13050932. Viruses. 2021. PMID: 34069827 Free PMC article.
-
Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome Triggered by COVID-19.Eur J Case Rep Intern Med. 2021 Feb 4;8(3):002264. doi: 10.12890/2021_002264. eCollection 2021. Eur J Case Rep Intern Med. 2021. PMID: 33768072 Free PMC article.
-
Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19.medRxiv [Preprint]. 2022 Sep 26:2022.09.25.22280335. doi: 10.1101/2022.09.25.22280335. medRxiv. 2022. PMID: 36203557 Free PMC article. Preprint.
References
-
- Ruscitti P., Berardicurti O., Barile A., Cipriani P., Shoenfeld Y., Iagnocco A. Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? Ann Rheum Dis. 2020 Nov;79(11):1515–1516. (PubMed PMID: 32434816) - PubMed
-
- Ruscitti P., Berardicurti O., Di Benedetto P., Cipriani P., Iagnocco A., Shoenfeld Y. Severe COVID-19, another piece in the puzzle of the hyperferritinemic syndrome an immunomodulatory perspective to alleviate the storm front. Immunol. 2020;11:1130. (PubMed PMID: 32574264. Pubmed Central PMCID: PMC7270352) - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous